Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Guerini-Rocco

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Antioxidants & Redox Signaling|May 9, 2006
Dynamic retention of Ero1alpha and Ero1beta in the endoplasmic reticulum by interactions with PDI and ERp44Mieko Otsu, Gloria Bertoli, Claudio Fagioli, et al.
Translational Lung Cancer Research|January 20, 2025
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a <i>STRN-ALK</i> fusion by artificial intelligence and molecular modelling: a case reportMassimo Barberis, Alessandra Rappa, Filippo de Marinis, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 11, 2023
Computational pathology to improve biomarker testing in breast cancer: how close are we?Elham Sajjadi, Chiara Frascarelli, Konstantinos Venetis, et al.
Life (Basel, Switzerland)|September 23, 2022
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic SchemesMariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, et al.
Journal of Personalized Medicine|July 29, 2023
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing MethodsFrancesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Journal of Clinical Medicine|January 24, 2019
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly PatientsCaterina Fumagalli, Chiara Catania, Alberto Ranghiero, et al.
Frontiers in Molecular Biosciences|April 20, 2023
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal testElham Sajjadi, Elena Guerini-Rocco, Elisa De Camilli, et al.
BMC Cancer|October 28, 2021
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profilingElham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Antioxidants & Redox Signaling|May 9, 2006
Dynamic retention of Ero1alpha and Ero1beta in the endoplasmic reticulum by interactions with PDI and ERp44Mieko Otsu, Gloria Bertoli, Claudio Fagioli, et al.
Translational Lung Cancer Research|January 20, 2025
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a <i>STRN-ALK</i> fusion by artificial intelligence and molecular modelling: a case reportMassimo Barberis, Alessandra Rappa, Filippo de Marinis, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|April 11, 2023
Computational pathology to improve biomarker testing in breast cancer: how close are we?Elham Sajjadi, Chiara Frascarelli, Konstantinos Venetis, et al.
Life (Basel, Switzerland)|September 23, 2022
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic SchemesMariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, et al.
Journal of Personalized Medicine|July 29, 2023
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing MethodsFrancesca Maria Porta, Elham Sajjadi, Konstantinos Venetis, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Liver toxicity in the era of immune checkpoint inhibitors: A practical approachCarmen Belli, Massimo Zuin, Luca Mazzarella, et al.
Journal of Clinical Medicine|January 24, 2019
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly PatientsCaterina Fumagalli, Chiara Catania, Alberto Ranghiero, et al.
Frontiers in Molecular Biosciences|April 20, 2023
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal testElham Sajjadi, Elena Guerini-Rocco, Elisa De Camilli, et al.
BMC Cancer|October 28, 2021
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profilingElham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
Cancers|July 9, 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor BoardsEdoardo Crimini, Matteo Repetto, Paolo Tarantino, et al.
Pageof 16